The Philippines National TB Program’s (NTP) laboratory network strategic plan (LNSP) aims to improve access to quality laboratory services, including establishing new facilities, adopting new diagnostic technologies, and strengthening the laboratory systems. The implementation of laboratory network (LNW) strengthening plans and the performance of the LNW require a comprehensive monitoring of activities to detect problems, document results (performance), and gather lessons from the process. However, many program managers find monitoring difficult to implement because of the lack of knowledge, skills, and operational support, especially for field visits. A contributing factor is management’s weak appreciation of the value of monitoring for program management and improvement. This document aims to provide guidance to health workers who are tasked with monitoring the LNW’s status and performance. In this document, we provide the readers with practical tips on how to monitor—from preparation, data collection, data management, and reporting to a list of indicators to guide data collection.
Archive | Quality AssuranceRSS feed for this section
Assessment of the Good Manufacturing Practices Inspection Program of the Bangladesh Directorate General of Drug Administration
As a part of its ongoing support to build the capacity of the DGDA, the Systems for Improved Access to Pharmaceuticals and Services (SIAPS) team conducted a rapid assessment of the capacity of the Good Manufacturing Practices (GMP) inspection program at the Directorate General of Drug Administration (DGDA). GMP is part of the quality assurance system for medicines, which helps to ensure that medicinal products are consistently produced and controlled to meet the quality standards appropriate to their intended use, as required by national drug regulatory authorities. The GMP inspection is also a critical component of the medicines registration review process.
To assess the capacity of the GMP inspection program of the DGDA, the SIAPS team reviewed onsite inspection practices as well as relevant documents. To evaluate the legal framework and current tools used by the DGDA inspectorate, the SIAPS team reviewed the applicable laws, regulations, standard operating procedures (SOPs), guidance documents, checklists, and inspection reports of the DGDA. To assess the current GMP inspection practices of the DGDA inspectorate, the SIAPS team accompanied DGDA inspectors to observe inspection practices at two GMP-certified manufacturing sites.
Analysis of the Regulatory Capacity to Assure the Quality of Antimalarial Medicines in Selected Countries of the Greater Mekong Subregion of Asia
SIAPS conducted a review of regulatory and quality assurance efforts in the GMS with the following objectives—
- To inform PMI of past and current initiatives to improve the capacity of the region to combat counterfeit, substandard, and banned antimalarial medicines
- To understand the current barriers to effective medicine quality control for malaria
- To recommend specific areas of focus or interventions to further improve regional and country capacity to combat counterfeit, substandard, and banned or illegal antimalarial medicines
Swaziland’s Ministry of Health has published its Pharmaceutical Strategic Plan, 2012-2016, serving as a roadmap for the revised national pharmaceutical policy. This report is intended to facilitate the monitoring and evaluation of implementation of the Strategic Plan. The report is a reflection of characteristics of the pharmaceutical sector in 2012.
Infection Control Assessment Tool: A Standardized Approach for Improving Hospital Infection Control Practices
South Africa’s Department of Health, in collaboration with SPS, adapted the Infection Control Assessment Tool (ICAT), first published in 2010, as a cutting-edge approach to identifying, controlling, and preventing health care-associated infections (HAIs). The ICAT is a simple and practical approach for assessing the adequacy of existing infection prevention and control practices and provides specific recommendations for improving practices and monitoring their effectiveness over time.
The project aimed to understand the current status and future plans of the Angolan public health logistics network, with the Central Procurement Agency for Medicines and Medical Supplies (Central de Compras de Medicamentos e meios medicos de Angola; CECOMA) as its principal focus. The team worked to identify weaknesses, gaps, strengths, opportunities, and potential threats in the system. The team worked to develop system-strengthening interventions and a plan for their implementation. The project staff worked to identify opportunities to build consensus among key supply chain stakeholders for the identified priorities and system-strengthening opportunities.
This tool was designed to improve practices for the prevention and control of infections by using easy-to-apply instruments that highlight deficiencies in current practices and suggesting corrective actions. The guide is one component of a standardized approach to reduce facility-acquired infections, the other component being the application of rapid cycles of quality improvement.
The SIAPS/SCMS/BLC Namibia e-Newsletter is a monthly newsletter that keeps you abreast of activities fundedby the USAID and implemented by MSH Namibia. Key focus areas are strengthening health systems, capacity building, and human resource development.
- The Use of Pharmaceutical Information for Decision Making in Namibia's National ART Program: Assessment Report
SIAPS conducted this assessment to determine the extent to which pharmaceutical information generated from the Electronic Dispensing Tool (EDT) and […]
The Directorate of Drugs and Medical Supplies (DDMS) plays a key role in providing technical guidance and setting strategic direction […]
- Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program Inventory of Key Technical Resources
The main purpose of this inventory is to serve as a reference to help stakeholders working in the pharmaceutical sector […]